Ketamine Mylan

Country: New Zealand

Lingwa: Ingliż

Sors: Medsafe (Medicines Safety Authority)

Ingredjent attiv:

Ketamine hydrochloride 115.3 mg/mL equivalent to Ketamine 100 mg/mL

Disponibbli minn:

Viatris Limited

INN (Isem Internazzjonali):

Ketamine hydrochloride 115.3 mg/mL (equivalent to Ketamine 100 mg/mL)

Dożaġġ:

200 mg/2mL

Għamla farmaċewtika:

Solution for injection

Kompożizzjoni:

Active: Ketamine hydrochloride 115.3 mg/mL equivalent to Ketamine 100 mg/mL Excipient: Benzethonium chloride Nitrogen Water for injection

Tip ta 'preskrizzjoni:

Class C4 Controlled Drug

Manifatturat minn:

CU Chemie Uetikon GmbH

Indikazzjonijiet terapewtiċi:

Ketamine is indicated: · as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. Ketamine is best suited for short procedures and it can be used with additional doses' for longer procedures · for the induction of anaesthesia prior to the administration of other general anaesthetic agents · to supplement low-potency agents' such as nitrous oxide.

Sommarju tal-prodott:

Package - Contents - Shelf Life: Vial, glass, 2 mL Type 1 (USP) closed with bromobutyl rubber stopper and aluminium cap - 5 dose units - 24 months from date of manufacture stored at or below 25°C protect from light 24 hours diluted stored at 2° to 8°C (Refrigerate, do not freeze) protect from light. in 5% dextrose, 0.9% sodium chloride, or water for injection - Vial, glass, 2 mL Type 1 (USP) closed with bromobutyl rubber stopper and aluminium cap - 10 dose units - 24 months from date of manufacture stored at or below 25°C protect from light 24 hours diluted stored at 2° to 8°C (Refrigerate, do not freeze) protect from light. in 5% dextrose, 0.9% sodium chloride, or water for injection

Data ta 'l-awtorizzazzjoni:

2014-12-10